Rifaximin-d<sub>6</sub>

Rifaximin-d6

CAT N°: 26101
Price:

213.00 181.05

Rifaximin-d6 is intended for use as an internal standard for the quantification of rifaximin (Item No. 16131) by GC- or LC-MS. Rifaximin is an antibiotic derived from rifamycin SV (Item No. 21441) that inhibits the growth of a variety of Gram-positive and Gram-negative bacteria in vitro, including Staphylococcus, Streptococcus, Enterococcus, H. influenzae, and N. gonorrhoeae (MIC50s = ?0.015, 50 = ~20 ?M) that reduces colonic damage, rectal bleeding, and diarrhea in PXR-humanized, but not wild-type or Pxr-null, mice with inflammatory bowel disease (IBD) induced by dextran sulfate sodium (DSS; Item No. 23250).{42471,42472} Rifaximin exhibits minimal intestinal absorption after oral administration and is, therefore, effective in eliminating bacteria in the gastrointestinal system.{26322,26320} Formulations containing rifaximin have been used in the treatment of traveler’s diarrhea caused by noninvasive E. coli, irritable bowel syndrome with diarrhea (IBS-D), and to reduce the risk of recurrence of overt hepatic encephalopathy.

We also advise you